Additional studies in different tumours with control samples and all isoforms are needed to clarify the complete consequences of Δ40p53 overexpression, its importance in a malfunctioning p53 pathway and the mechanistic implications of its deregulation. The gene discussed is TP53; the disease is neoplasm.